RELMADA THERAPEUTICS, INC.
Patent Owner
Stats
- 3 US PATENTS IN FORCE
- 4 US APPLICATIONS PENDING
- Nov 23, 2017 most recent publication
Details
- 3 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 423 Total Citation Count
- Jan 29, 2007 Earliest Filing
- 3 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
| Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
2017/0333,410 Dermal Pharmaceutical Compositions of 1-Methyl-2',6'-Pipecoloxylidide and Method of UseApr 13, 11Nov 23, 17[A61K]
2016/0176,890 Oral Pharmaceutical Compositions of Buprenorphine and Another Opioid Receptor AgonistMar 01, 16Jun 23, 16[A61K, C07D]
2012/0065,221 Extended Release Oral Pharmaceutical Compositions of 3-Hydroxy-N-Methylmorphinan and Method of UseFeb 26, 10Mar 15, 12[A61K, A61P]
2011/0097,395 Oral Pharmaceutical Compositions of Buprenorphine and Method of UseMar 09, 09Apr 28, 11[A61K, A61P]
Recent Patents
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2016/0235,740 Compositions of (-)-17-(Cyclobutylmethyl)Morphinan-3,14,-DiolAbandonedApr 22, 16Aug 18, 16[A61K]
2012/0178,771 Oral Pharmaceutical Compositions of Buprenorphine and Method of UseAbandonedSep 09, 11Jul 12, 12[A61K]
2009/0082,466 Abuse Resistant and Extended Release Formulations and Method of Use ThereofAbandonedJan 29, 07Mar 26, 09[A61K]
Top Inventors for This Owner
| Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.
